Oneness Biotech Co., Ltd. (TPEX:4743)
Taiwan · Delayed Price · Currency is TWD 50.20
+4.55 (9.97%)
Nov 13, 2026, 1:21 PM CST
Oneness Biotech Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 139.97 | 129.12 | 117.93 | 86.78 | 1,066 | 65.77 |
Revenue Growth | 19.30% | 9.50% | 35.89% | -91.86% | 1520.25% | 58.07% |
Gross Profit Gross Profit Growth | 45.81 | 39.88 | 63.03 | 32.56 | 844.39 | 45.04 |
Operating Income Operating Income Growth | -824.81 | -803.01 | -1,086 | -1,097 | -241.45 | -878.14 |
Net Income Net Income Growth | -216.42 | -1,045 | -1,165 | -1,313 | 359.98 | -403.3 |
Earnings Per Share EPS Growth | -0.45 | -2.18 | -2.44 | -2.77 | 0.76 | -0.89 |
EPS Growth | - | - | - | - | - | - |
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Organic and Health-related Products Organic and Health-related Products Growth | 46.42 | 16.31 | 24.84 | 38.79 | 30.62 |
Research and development of new medicine Research and development of new medicine Growth | 82.7 | 114.22 | 72.56 | 1,039 | 51.56 |
Eliminations Eliminations Growth | - | -12.59 | -10.62 | -12.06 | -16.42 |
Total Total Growth | 129.12 | 117.93 | 86.78 | 1,066 | 65.77 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 5,362 | 5,823 | 7,019 | 7,773 | 8,047 | 7,806 |
Total Debt Total Debt Growth | 338.31 | 370.73 | 406.35 | 432.2 | 263.34 | 283.07 |
Net Cash (Debt) Net Cash Growth | 5,024 | 5,453 | 6,613 | 7,341 | 7,783 | 7,523 |
Net Cash Growth | -8.64% | -17.54% | -9.92% | -5.69% | 3.46% | -6.13% |
Net Cash Per Share Net Cash Per Share Growth | 10.50 | 11.37 | 13.83 | 15.50 | 16.50 | 16.52 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -225.95 | -460.24 | -345.58 | -422.18 | -881 | -288.89 |
Capital Expenditures CapEx Growth | -12.27 | -21.96 | -49.71 | -90.06 | -87.35 | -95.35 |
Free Cash Flow Free Cash Flow Growth | -238.22 | -482.21 | -395.28 | -512.23 | -968.35 | -384.24 |
Free Cash Flow Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 32.73% | 30.88% | 53.45% | 37.52% | 79.25% | 68.49% |
Operating Margin | -589.28% | -621.89% | -920.96% | -1263.64% | -22.66% | -1335.27% |
Pretax Margin | -143.80% | -817.87% | -974.96% | -1517.90% | 42.38% | -602.09% |
Profit Margin | -154.62% | -809.13% | -988.03% | -1512.82% | 33.78% | -613.25% |
FCF Margin | -170.19% | -373.45% | -335.20% | -590.25% | -90.88% | -584.26% |
Fiscal Year | FY 2022 |
|---|---|
| Period Ending | Dec '22 Dec 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.084 |
Dividend Per Share Growth | - |
Dividend Yield | 0.04% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | 264.52 | - |
Forward PE | - | 160.48 | 160.48 | 160.48 | - | - |
PS Ratio | 171.97 | 206.01 | 353.46 | 1014.35 | 89.36 | 1664.92 |